Substantial proportions of identical β-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors

Cellular Immunology

Volumn 234, Issue 2, 2005, Pages 81-101

  Pappas, John ^a   Jung, Weon Ju ^a   Barda, Angeliki K ^a   Lin, Wan L ^a   Fincke, John E ^a   Purev, Enkhtuya ^a   Radu, Maria ^a   Gaughan, John ^a   Helm, C William ^a   Hernandez, Enrique ^a   Freedman, Ralph S ^b   Platsoucas, Chris D ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Epithelial ovarian carcinoma; T cell receptor

Indexed keywords

ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BETA CHAIN; BINOMIAL DISTRIBUTION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ADULT; AGED; AMINO ACID SEQUENCE; BASE SEQUENCE; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ALIGNMENT; T-LYMPHOCYTES;

EID: 23944459338     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.05.001     Document Type: Article

References (104)

1. C.D. Platsoucas, J.E. Fincke, J. Pappas, W.-J. Jung, M. Heckel, R. Schwarting, E. Magira, D. Monos, and R.S. Freedman Immune responses to human tumors: development of tumor vaccines Anticancer Res. 23 2003 1969
2. R.S. Freedman, and C.D. Platsoucas Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor-infiltrating lymphocytes Cancer Treatment Res. 82 1996 115
3. R.S. Freedman, A.P. Kudelka, C.F. Verschraegen, and C.D. Platsoucas Progress toward tumor specific immunity in carcinomas of the ovary and breast J.J. Kavanagh S.E. Singletary N. Einhorn A.D. DePetrillo Cancer in Women 1998 Blackwell Science Publication Malden, Oxford, London, Berlin, Tokyo 30
4. S.A. Rosenberg Progress in human tumor immunology and immunotherapy Nature 411 2001 382
5. C.G. Ioannides, C.D. Platsoucas, S. Rashed, J.T. Wharton, C.L. Edwards, and R.S. Freedman Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites Cancer Res. 51 1991 4257
6. C.G. Ioannides, R.S. Freedman, C.D. Platsoucas, S. Rashed, and Y.P. Kim Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells J. Immunol. 146 1991 1700
7. S. Kooi, R.S. Freedman, J. Rodriguez-Villanueva, and C.D. Platsoucas Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma. Tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells Lymphokine Cytokine Res. 12 1993 429
8. G.E. Peoples, M.P. Davey, P.S. Goedegebuure, D.D. Schoof, and T.J. Eberlein T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer J. Immunol. 151 1993 5472
9. G.E. Peoples, P.S. Goedegebuure, J.V. Andrews, D.D. Schoof, and T.J. Eberlein HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer J. Immunol. 151 1993 5481
10. G.E. Peoples, P.S. Goedegebuure, R. Smith, D.C. Linehan, I. Yoshino, and T.J. Eberlein Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide Proc. Natl. Acad. Sci. USA 92 1995 432
11. G.E. Peoples, I. Yoshino, C.C. Douville, J.V. Andrews, P.S. Goedegebuure, and T.J. Eberlein TCR Vbeta3+ and Vbeta6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers J. Immunol. 152 1994 4993
12. I. Yoshino, P.S. Goedegebuure, G.E. Peoples, A.S. Parikh, J.M. DiMaio, H.K. Lyer, A.F. Ganzar, and T.J. Eberlein Her2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer Cancer Res. 54 1994 3387
13. V. Ramakrishna, D.R. Negri, V. Brusi, R. Fontanelli, S. Canevari, G. Bolis, C. Castelli, and G. Parmiani Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells Int. J. Cancer 73 1997 143
14. A. Yamada, K. Kawano, N. Harashima, F. Niiya, K. Nagai, K. Kobayashi, T. Mine, K. Ushijima, T. Nishida, and K. Itoh Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer Cancer Immunol. Immunother. 48 1999 147
15. D. Monos, J. Pappas, E. Magira, J. Gaughan, R. Aplenc, L.I. Sakkas, R.S. Freedman, J.D. Reveille, and C.D. Platsoucas Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer Human Immunology 66 2005 554
16. T. Boehm, and T.H. Rabbitts The human T-cell receptor genes are targets for chromosomal abnormalities in T-cell tumors FASEB J. 3 1989 2344
17. B. Arden, S.P. Clark, D. Kabelitz, and T.W. Mak Human T-cell receptor variable gene segment families Immunogenetics 42 1995 455
18. C.A. Janeway P. Travers W. Mark J.D. Capra fourth ed. Immunobiology: The Immune System in Health and Disease 1999 Current Biology Publications New York 635
19. J.E. Slansky Antigen-specific T cells: analyses of the needles in the haystack PLoS Biol. 1 2003 329
20. T.P. Arstila, A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky A direct estimate of the human alphabeta T cell receptor diversity Science 286 1999 958
21. P.F. Chen, and C.D. Platsoucas Development of the non-palindromic adaptor polymerase chain reaction (NPA-PCR) for the amplification of alpha- and beta-chain T-cell receptor cDNAs Scand. J. Immunol. 35 1992 539
22. C.A. Slachta, V. Jeevanandam, B. Goldman, W.L. Lin, and C.D. Platsoucas Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal populations of T cells. Persistence of identical clonally expanded β-chain T-cell receptor transcripts from the early posttransplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries) J. Immunol. 165 2000 369
23. C.A. Slachta, V. Jeevanandam, B. Goldman, W.L. Lin, and C.D. Platsoucas Coronary arteries with chronic rejection contain oligoclonal T cells. Persistence of clonally expanded T-cell receptor (TCR) transcripts from the early post-transplantation period through chronic rejection Transplant. Proc. 33 2001 452
24. E.L. Oleszak, W.L. Lin, A. Legido, J. Melvin, H. Hardison, B.E. Hoffman, C.D. Katsetos, and C.D. Platsoucas Oligoclonal T cells are present in the CSF of a child with a recurrent disseminated MS-like demyelinating disease following Hepatitis A infection Clin. Diag. Lab. Immunol. 8 2001 984
25. L.I. Sakkas, B. Xu, C.M. Artlett, S. Lu, S.A. Jimenez, and C.D. Platsoucas Oligoclonal T cell expansion in the skin of patients with systemic sclerosis J. Immunol. 168 2002 3649
26. B. Xu, L.I. Sakkas, B.I. Goldman, V. Jeevanandam, J. Gaughan, E.L. Oleszak, and C.D. Platsoucas Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of cardiac allografts with chronic rejection Cell Immunol. 225 2003 75
27. W.L. Lin, J.E. Fincke, L. Sharer, D. Monos, S. Lu, J. Gaughan, C.D. Platsoucas, and E.L. Oleszak Oligoclonal T cells are infiltrating the brain of children with AIDS: sequence analysis revealed high proportions of identical beta-chain T-cell receptor (TCR) transcripts Clin. Exp. Immunol. 141 2005 338
28. J.E. Fincke, W.L. Lin, D.W. Laske, A. Kendler, M. Curtis, R. Schwarting, and C.D. Platsoucas Oligoclonal tumor infiltrating lymphocyte populations in glioblastoma J. Neuroimmunol. 154 2004 176
29. R.S. Freedman, B. Tomasovic, S. Templin, E.N. Atkinson, A. Kudelka, C.L. Edwards, and C.D. Platsoucas Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy J. Immunol. Methods 167 1994 145
30. R.S. Freedman, C.L. Edwards, J.J. Kavanagh, A. Kudelka, R.L. Katz, C.H. Carrasco, E.N. Atkinson, B. Tomasovic, S. Templin, and C.D. Platsoucas Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low dose of rIL2. A pilot trial J. Immunother. 16 1994 198
31. L.I. Sakkas, C. Scanzello, N. Johanson, J. Burkholder, A. Mitra, P. Salgame, C.D. Katsetos, and C.D. Platsoucas T cells and T-cell derived cytokine transcripts in the synovial membrane of patients with osteoarthritis Clin. Diag. Lab. Immunol. 5 1998 430
32. D.G. Spinella, J.M. Robertson, Analysis of human T-cell repertoires by PCR, in: K.B. Mullis, F. Ferre, R.A. Gibbs (Eds.), The Polymerase Chain Reaction, 1994, p. 110.
33. Y.W. Choi, B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler Interaction of Staphylococcus aureus toxin "superantigens" with human T cells Proc. Natl. Acad. Sci. USA 86 1989 8941
34. U. Malhotra, R. Spielman, and P. Concannon Variability in T-cell receptor Vβ gene usage in human peripheral blood lymphocytes; studies of identical twins, sublines, and insulin-dependent diabetes mellitus patients J. Immunol. 149 1992 1802
35. J. Even, A. Lim, I. Puisieux, L. Ferradini, P.-Y. Dietrich, A. Toubert, T. Hercend, F. Triebel, C. Pannetier, and P. Kourilsky T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor β-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases Res. Immunol. 146 1995 65
36. D. Hanahan Studies on transformation of Escherichia coli with plasmids J. Mol. Biol. 166 1983 557
37. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res. 25 1997 3389
38. G.W. Snedecor, and W.G. Cohran Statistical Methods 1989 Iowa State University Press Ames, Iowa 503
39. C. Genevee, A. Diu, J. Niierat, A. Caignard, P.Y. Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend An experimentally validated panel of subfamily-specific oligonucleotide primers (Valpha1-w29/Vbeta1-w24) for the study of T-cell receptor variable V gene segment usage by polymerase chain reaction Eur. J. Immunol. 22 1992 1261
40. S. Wei, P. Charmley, M.A. Robinson, and P. Concannon The extent of the human germline T-cell receptor Vβ gene segment repertoire Immunogenetics 40 1994 27
41. L. Ferradini, S. Roman-Roman, J. Azocar, H. Michalaki, F. Triebel, and T. Hercend Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional Vbeta subfamilies Eur. J. Immunol. 21 1991 935
42. S.P. Clarke, B. Arden, D. Kabelitz, and T.W. Mak Comparison of human and mouse T-cell receptor variable gene segment subfamilies Immunogenetics 42 1995 531
43. K. Andreassen, S. Bendiksen, E. Kjeldsen, M. Van Ghelue, U. Moens, E. Arnesen, and O.P. Rekvig T cell autoimmunity to histones and nucleosomes is a latent property of the normal immune system Arthritis Rheum. 46 2002 1270
44. H. Hara, M. Morita, T. Iwaki, T. Hatae, Y. Itoyama, T. Kitamoto, S. Akizuki, I. Goto, and T. Watanabe Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis J. Exp. Med. 180 1994 831
45. M. Saito, I. Higuchi, A. Saito, S. Izumo, K. Usuku, C.R. Bangham, and M. Osame Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis J. Infect. Dis. 186 2002 1231
46. C. Ciurli, D.N. Posnett, R.P. Sekaly, and F. Denis Highly biased CDR3 usage in restricted sets of beta chain variable regions during viral superantigen 9 response J. Exp. Med. 187 1998 253
47. R. Duchmann, C. Lambert, E. May, T. Hohler, and E. Marker-Hermann CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins Clin. Exp. Immunol. 123 2001 315
48. K. Willenbrock, A. Roers, C. Seidl, H.H. Wacker, R. Kuppers, and M.L. Hansmann Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements Am. J. Pathol. 158 2001 1851
49. D.F. Barber, D. Obeso, R. Garcia-Hoyo, J.A. Villadangos, and J.A. Lopezde Castro T-cell receptor usage in alloreactivity against HLA-B*2703 reveals significant conservation of the antigenic structure of B*2705 Tissue Antigens 47 1996 478
50. H. Babbe, A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schroeder, M. Deckert, S. Schmidt, R. Ravid, and K. Rajewsky Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction J. Exp. Med. 192 2000 393
51. P.J. Lehner, E.C. Wang, P.A. Moss, S. Williams, K. Platt, S.M. Friedman, J.L. Bell, and L.K. Borysiewicz Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment J. Exp. Med. 181 1995 79
52. G. Giegerich, M. Pette, E. Meinl, J.T. Epplen, H. Wekerle, and A. Hinkkanen Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes Eur. J. Immunol. 22 1992 753
53. M.D. Howell, J.P. Diveley, K.A. Lundeen, A. Esty, S.T. Winters, D.J. Carlo, and S.W. Brostoff Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis Proc. Natl. Acad. Sci. USA 88 1991 10921
54. H. Soudeyns, P. Champagne, C.L. Holloway, G.U. Silvestri, N. Ringuette, J. Samson, N. Lapointe, and R.P. Sekaly Transient T cell receptor beta-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotyping J. Infect. Dis. 181 2000 107
55. N. Dulphy, M.-A. Peyrat, V. Tieng, C. Douay, C. Rabian, R. Tamouza, S. Laoussadi, F. Berenbaum, A. Chabot, M. Bonneville, D. Charron, and A. Toubert Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27 J. Immunol. 162 1999 3830
56. L. Kjer-Nielsen, C.S. Clements, A.W. Purcell, A.G. Brooks, J.C. Whisstock, S.R. Burrows, J. McCluskey, and J. Rossjohn A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity Immunity 18 2003 53
57. A.P. Fontenot, M.T. Falta, B.M. Freed, L.S. Newman, and B.L. Kotzin Identification of pathogenic T cells in patients with beryllium-induced lung disease J. Immunol. 163 1991 1019
58. J. Hong, Y.C. Zang, M.V. Tejada-Simon, M. Kozovska, S. Li, R.A. Singh, D. Yang, V.M. Rivera, J.K. Killian, and J.Z. Zhang A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis J. Immunol. 163 1999 3530
59. A. Chott, C.S. Probert, G.G. Gross, R.S. Blumberg, and S.P. Balk A common TCR beta-chain expressed by CD8+ intestinal mucosa T cells in ulcerative colitis J. Immunol. 156 1996 3024
60. M.J. Maeurer, D.M. Martin, W.J. Storkus, and M.T. Lotze TCR usage in CTLs recognizing melanoma/melanocyte antigens Immunol. Today 16 1995 603
61. T. Maruyama, I. Saito, S. Miyake, H. Hashimoto, K. Sato, H. Yagita, K. Okumura, and N. Miyasaka A possible role of two hydrophobic amino acids in antigen recognition by synovial T cells in rheumatoid arthritis Eur. J. Immunol. 23 1993 2059
62. L. Wang, K. Tadokoro, K. Tokunaga, S. Uchida, S. Moriyama, M. Bannai, S. Mitsunaga, K. Takai, and T. Juji Restricted use of T-cell receptor V beta genes in posttransfusion graft-versus-host disease Transfusion 37 1997 1184
63. P. Concannon, L.A. Pickering, P. Kung, and L. Hood Diversity and structure of human T-cell receptor β-chain variable region genes Proc. Natl. Acad. Sci. USA 83 1986 6598
64. M.M. Davis, J.J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien Ligand recognition by alpha beta T-cell receptors Annu. Rev. Immunol. 16 1998 523
65. H. Schild, N. Mavaddat, C. Litzenberger, E.W. Ehrich, M.M. Davis, J.A. Bluestone, L. Matis, R.K. Draper, and Y.-H. Chien The nature of major histocompatibility complex recognition by γδ T cells Cell 76 1994 29
66. H. Li, M.I. Labedeva, A.S. Llera, B.A. Fields, M.B. Brenner, and R.A. Mariuzza Structure of the Vδ domain of a human γδ T-cell antigen receptor Nature 391 1998 502
67. S.P. Balk, E.C. Ebert, R.L. Blumenthal, F.V. McDermott, K.W. Wucherpfennig, S.B. Landau, and R.S. Blumberg Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes Science 253 1991 1411
68. P.A. Sieling, D. Chatterjee, S.A. Porcelli, T.I. Prigozy, R.J. Mazzaccaro, T. Soriano, B.R. Bloom, M.B. Brenner, M. Kronenberg, P.J. Brennan, and R.I. Modlin CD1-restricted T cell recognition of microbial lipoglycan antigens Science 269 1995 227
69. Y. Tanaka, C.T. Morita, Y. Tanaka, E. Nieves, M.B. Brenner, and B.R. Bloom Natural and synthetic non-peptide antigens recognized by human γδ T cells Nature 375 1995 155
70. C.T. Morita, E.M. Beckman, J.F. Bukowski, Y. Tanaka, H. Band, B.R. Bloom, D.E. Golan, and M.B. Brenner Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells Immunity 3 1995 495
71. R. Sciammas, R.M. Johnson, A.I. Sperling, W. Brady, P.S. Linsley, P.G. Spear, F.W. Fitch, and J.A. Bluestone Unique antigen recognition by a herpesvirus-specific TCR-γδ cell J. Immunol. 152 1994 5392
72. E.M. Shevach Regulatory T cells in autoimmunity Annu. Rev. Immunol. 18 2000 423
73. U.K. Liyanage, T.T. Moore, H.G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, J.A. Drebin, S.M. Strasberg, T.J. Eberlein, P.S. Goedegebuure, and D.C. Linehan Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J. Immunol. 169 2002 2756
74. E.Y. Woo, C.S. Chu, T.J. Goletz, K. Schlienger, H. Yeh, G. Coukos, S.C. Rubin, L.R. Kaiser, and C.H. June Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res. 61 2001 4766
75. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.I. Knutson, L. Chen, and W. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat. Med. 10 2004 942
76. A.M. Thornton, and E.M. Shevach Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific J. Immunol. 164 2000 183
77. A.E. Loercher, M.A. Nash, J.J. Kavanagh, C.L. Edwards, C.D. Platsoucas, and R.S. Freedman Identification of an IL-10-producing, HLA-DR-negative, monocyte subset in the malignant ascites of patients with ovarian carcinoma, which inhibits cytokine protein expression and proliferation of autologous T cells J. Immunol. 163 1999 6251
78. C.G. Ioannides, C.D. Platsoucas, J.M. Bowen, J.T. Wharton, and R.S. Freedman Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate therapy Anticancer Res. 9 1989 81
79. P.-F. Chen, Y.-D. Li, R. Pollock, M. Ross, and C.D. Platsoucas Fresh tumor-infiltrating lymphocytes from certain patients with malignant melanoma are comprised of oligoclonal T-cells: sequence analysis of the αβ T-cell receptor cDNAs Proc. Am. Assoc. Cancer Res. 33 1992 309
80. L. Ferradini, A. Mackensen, C. Genevee, J. Bosq, P. Duvillard, M.F. Avril, and T. Hercend Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion J. Clin. Invest. 91 1993 1183
81. P. Thor Straten, J. Scholler, K. Hou-Jensen, and J. Zeuthen Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas Int. J. Cancer 56 1994 78
82. I. Puisieux, J. Even, C. Panuetiev, F. Joteveau, M. Faurof, and P. Kourilsky Oligoclonality of tumor-infiltrating lymphocytes from human melanomas J. Immunol. 153 1994 2807
83. S. Mandruzzato, E. Rossi, F. Bernardi, V. Tosello, B. Macino, G. Basso, V. Chiarion-Sileni, C.R. Rossi, C. Montesco, and P. Zanovello Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient J. Immunol. 169 2002 4017
84. H. Echchakir, I. Vergnon, G. Dorothee, D. Grunenwald, S. Chouaib, and F. Mami-Chouaib Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung Int. Immunol. 12 2000 537
85. H. Echchakir, C. Asselin-Paturel, G. Dorothee, I. Vergnon, D. Grunenwald, S. Chouaib, and F. Mami-Chouaib Analysis of T-cell-receptor beta-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas Int. J. Cancer 81 1999 205
86. G. Perrin, V. Schnuriger, A.L. Quiquerez, P. Saas, C. Pannetier, N. de Tribolet, J.M. Tiercy, J.P. Aubry, P.Y. Dietrich, and P.R. Walker Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset Int. Immunol. 11 1999 1337
87. K. Hayashi, K. Yonamine, K. Masuko-Hongo, T. Iida, K. Yamamoto, K. Nishioka, and T. Kato Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans Gynecol. Oncol. 74 1999 86
88. K. Itoh, C.D. Platsoucas, and C.M. Balch Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor J. Exp. Med. 168 1988 1419
89. S.A. Rosenberg, J.R. Yannelli, J.C. Yang, S.L. Topalian, D.J. Schwartzentruber, J.S. Weber, D.R. Parkinson, C.A. Seipp, J.H. Einhorn, and D.E. White Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2 J. Natl. Cancer Inst. 86 1994 1159
90. M.E. Dudley, J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, M.R. Robinson, M. Raffeld, P. Duray, C.A. Seipp, L. Rogers-Freezer, K.E. Morton, S.A. Mavroukakis, D.E. White, and S.A. Rosenberg Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 2002 850
91. P. Chomez, O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas An overview of the MAGE gene family with the identification of all human members of the family Cancer Res. 61 2001 5544
92. M.J. Scanlan, A.O. Gure, A.A. Jungbluth, L.J. Old, and Y.T. Chen Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol. Rev. 188 2002 22
93. A. Yamada, A. Kataoka, S. Shichijo, T. Kamura, Y. Imai, T. Nishida, and K. Itoh Expression of MAGE-1, MAGE-2, MAGE-3/-6, and MAGE-4a/-4b genes in ovarian tumors Int. J. Cancer 64 1995 388
94. V. Russo, P. Dalerba, A. Ricci, C. Bonazzi, B.E. Leone, C. Mangioni, P. Allavena, C. Bordignon, and C. Traversari MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas Int. J. Cancer 67 1996 457
95. A.M. Gillespie, S. Rodgers, A.P. Wilson, J. Tidy, R.C. Rees, R.E. Coleman, and A.K. Murray MAGE, BAGE and GAGE: tumor antigen expression in benign and malignant ovarian tissue Br. J. Cancer 78 1998 816
96. A. Hofmann, and I. Ruschenburg mRNA detection of tumor-rejection genes BAGE, GAGE and MAGE in peritoneal fluid from patients with ovarian carcinoma as a potential diagnostic tool Cancer 96 2002 187
97. E. Yakirevich, E. Sabo, O. Lavie, S. Mazareb, G.C. Spagnoli, and M.B. Resnick Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms Clin. Cancer Res. 9 2003 6453
98. K. Odunsi, A.A. Jungbluth, E. Stockert, F. Qian, S. Gnjatic, J. Tammela, M. Intengan, A. Beck, B. Keitz, D. Santiago, B. Williamson, M.J. Scanlan, G. Ritter, Y.-T. Chen, D. Driscoll, A. Sood, S. Lele, and L.J. Old NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer Cancer Res. 63 2003 6076
99. D.F. Stern, P.A. Heffernan, and R.A. Weinberg P185 a product of a neu protooncogene is a receptor-like protein associated with tyrosine kinase activity Mol. Cell. Biol. 6 1986 1721
100. R.M. Neve, H.A. Lane, and N.E. Hynes The role of overexpressed HER2 in transformation Ann. Oncol. 12 Suppl. 1 2001 S9
101. T. Cooke, J. Reeves, A. Lanigan, and P. Stanton HER2 as a prognostic and predictive marker for breast cancer Ann. Oncol. 12 Suppl. 1 2001 S23
102. M.L. Disis, J.W. Smith, A.E. Murphy, W. Chen, and M.A. Cheever In vitro generation of human cytolytic T cells specific for peptides derived from the HER-2/neu protooncogene protein Cancer Res. 54 1994 1071
103. M.L. Disis, E. Calenoff, G. McLaughlin, A.E. Murphy, W. Chen, B. Groner, M. Jeschke, N. Lydon, E. McGlynn, and R.B. Livingston Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer Cancer Res. 54 1994 16
104. T.Z. Zaks, and S.A. Rosenberg Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors Cancer Res. 58 1998 4902